LataMed AI to Discuss AI in Healthcare and Systems Engineering at Universidad Santa Maria

LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced its participation in the 'Artificial Intelligence & Health Markets 2026' conference, scheduled for August 13 and 14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event, organized through its Venezuelan operating subsidiary LATAMEDAI VE, will bring together students, faculty, and professionals from systems engineering and healthcare-related fields, including pharmacy, dentistry, and laboratory sciences, to explore practical applications of AI and automation.

The conference serves as a platform for LataMed AI to discuss the evolving role of AI in healthcare and systems engineering, focusing on how AI-supported tools can assist professionals with medical-data evaluation, clinical workflows, and operational decision-making. The company also plans to examine how automation can enhance the organization, reliability, and efficiency of technology systems in healthcare and other complex environments. A key emphasis will be on maintaining qualified professional oversight when implementing AI, as LataMed AI's technologies are designed to augment human capabilities and support informed decision-making rather than replace the independent judgment of healthcare professionals, engineers, and other qualified individuals.

Additional topics at the conference will include the integration of AI into existing systems, responsible data use, privacy and information security, operational risk management, and practical considerations for developing and deploying technology in healthcare settings. LataMed AI will also discuss the continued development of its healthcare technology ecosystem, particularly the roles of CardioAI, PulmoAI, and NeuroAI in its broader strategy. These AI-supported platforms are being developed to assist healthcare professionals in evaluating and managing cardiovascular, pulmonary, and neurological health information, subject to ongoing development, testing, and regulatory approval.

Dr. Kevin Rodan Levy, CEO of LataMed AI, expressed the importance of the event, stating, 'Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America.'

The company believes that engagement with universities and educational institutions will increase awareness of emerging healthcare technologies, encourage responsible discussion about AI, and strengthen relationships with future professionals. Participation in the conference aligns with LataMed AI's broader strategy of supporting education, professional collaboration, and the responsible adoption of digital healthcare infrastructure throughout the region. The company intends to continue evaluating opportunities to participate in academic, healthcare, and technology forums that align with its business and educational objectives.

For more information about LataMed AI, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.